Diasorin SpA (MIL:DIA) Valuation Rank


MIL:DIA Diasorin SpA MIL:DIA
69 GF Score
Price €67.76
GF Value €90.16
Valuation Modestly Undervalued
! 5 Warning Signs
View Full Analysis

What is Diasorin SpA Valuation Rank?

The Valuation Rank measures the current valuation of a business relative to other companies in the same industry and its own historical valuation. The companies are split in equal numbers and then ranked from 1 to 10, with 10 as the most undervalued and 1 as the most overvalued.

  1. Three factors:
    • Absolute valuation (medpsvalue) relative to current stock price, rank among all companies
    • Historical valuation over the past 10 years. Rank pe, ps, pocf, ev2ebit over their own historical values
    • Industry relative valuation
  2. Companies without enough data is not ranked
  3. Companies with negative earnings are ranked lower

These three factors are used to calculate the value score for every eligible company, with values from 1 to 10. The final ranked companies are split in equal numbers and ranked from 1 to 10, with 10 as the most undervalued, and 1 as the most overvalued. The numbers of companies in each rank are the same.

Diasorin SpA Valuation Rank Related Terms

MIL:DIA
69GF Score
Diasorin SpA MIL:DIA
Valuation Rank is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Diasorin SpA (MIL:DIA) Overvalued in 2026?

Based on GuruFocus' analysis, Diasorin SpA stock appears to be undervalued. The current stock price of €67.76 is trading 24.8% below its estimated GF Value™ of €90.16. GuruFocus considers Diasorin SpA to be Modestly Undervalued.

Key valuation signals for MIL:DIA:

  • Valuation Rank:
  • GF Value™: €90.16 vs. price of €67.76 (24.8% below fair value)
  • GF Score™: 69/100 with 5 warning signs

No single metric tells the full story. See the MIL:DIA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Diasorin SpA Business Description

Address Via Crescentino Snc, Saluggia, Vercelli, ITA, 13040
Diasorin develops and manufactures a broad portfolio of in vitro diagnostics for detecting pathogens and sample contamination from the human body, as well as for use in industrial settings, such as food and water contamination testing. The company operates three segments: immunodiagnostics (69% of sales), molecular diagnostics (16%), and licensed technologies (14%). Diasorin was an important manufacturer of covid tests, which boosted its profits during the pandemic, but this segment's importance has decreased over the years, and in 2025, it accounted for only 1% of total sales.
69GF Score

Get the complete analysis for MIL:DIA

Valuation Rank is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€67.76
Price
€90.16
GF Value